Evaluation of Tricuspid Valve Repair Without Annuloplasty Ring in Intravenous Drug Abusers

Jawad, Mohammed Abd Al; Ammar, Ayman; Nahas, Yasser El; Ahmed, Ahmed; Kilany, Ibrahim; Kerdany, Ahmed El

doi:10.1016/j.athoracsur.2019.08.022

Cited by 3 publications

(8 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Author details 1 Department of Cardiac Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China. 2 School of Public Health Fujian Medical University, Fuzhou,China. 3 Department of emgerncy, Nanjing County Hospital, Zhangzhou, Fujian, China.…”

Section: Authors'contributionsmentioning

confidence: 99%

“…[ 1] In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective endocarditis involving the right heart of the tricuspid valve has gradually increased. [ 2] At present, while removing vegetation, the surgical treatment of diseased tricuspid valve mainly includes two types of surgery: tricuspid valvuloplasty(TVP) and tricuspid valve replacement(TVR). [ 3] [4] TVP mainly includes Kay suture angioplasty, De Vega angioplasty, pericardial patch angioplasty, and arti cial annuloplasty.…”

Section: Introductionmentioning

confidence: 99%

“…[ 2] At present, while removing vegetation, the surgical treatment of diseased tricuspid valve mainly includes two types of surgery: tricuspid valvuloplasty(TVP) and tricuspid valve replacement(TVR). [ 3] [4] TVP mainly includes Kay suture angioplasty, De Vega angioplasty, pericardial patch angioplasty, and arti cial annuloplasty.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis

Xie

Chen

et al. 2021

Preprint

View full text Add to dashboard Cite

Background In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective endocarditis involving the right heart of the tricuspid valve has gradually increased.At present, there is no systematic report on surgical treatment of tricuspid infective endocarditis. This paper summarizes the experience of surgical treatment of 56 patients with tricuspid infective endocarditis in our hospital and analyzes its clinical effect. Methods From January 2006 to August 2019, 56 cases of tricuspid infective endocarditis treated by tricuspid valve surgery in our hospital were analyzed retrospectively.including 23 cases of tricuspid valvuloplasty (TVP) and 33 cases of tricuspid valve replacement (TVR). All patients were complicated with tricuspid valve vegetations or moderate and severe tricuspid regurgitation and had surgical indications.The perioperative data were collected and followed up for 6 months to 14 years to summarize and analyze the clinical effect of surgical treatment of tricuspid infective endocarditis. Results Compared with TVR group, the CPB time (79.68 ± 19.02min VS 107.39 ± 25.64min, P < 0.01), ACC time (50.29 ± 16.14min VS 65.52 ± 20.62min, P < 0.01), postoperative mechanical ventilation time (18.65 ± 8.18h VS 44.85 ± 57.68h, P < 0.01) and ICU stay time (38.13 ± 21.80h VS 102.64 ± 142.11h, P = 0.015) in TVP group were shorter. The perioperative red blood cell transfusion (4.87 ± 3.81U VS 7.55 ± 5.42U, P < 0.01) and the incidence of postoperative complications (8.7% VS 33.3%, P < 0.01) were lower.Perioperative death occurred in 1 case in the TVR group, and there was no perioperative death in the TVP group, There was no significant difference between the two groups(3.03% VS 0, P = 0.855). A total of 52 cases were followed up for an average of (5.50 ± 3.79) years.The postoperative 3-year, 5-year and 7-year survival rate were 100%,100%,91.7% in TVP group and 95.2%, 93.8% and 87.5%.The 5-year and 10-year reoperation rate were 0%, 0% in TVP group and 6.7%, 20% in TVR group. Conclusion Surgical treatment of severe tricuspid valve endocarditis has achieved good mid-term clinical results, and the rate of avoiding reoperation is better in TVP group than in TVR group.

show abstract

Section: Authors'contributionsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis

Xie

Chen

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Operative indications are limited, although studies formally assessing surgical timing and indications in TVIE are lacking. 4,5 In this issue of The Annals of Thoracic Surgery, Abd Al Jawad and colleagues 6 from Ain Shams University in Cairo, Egypt describe short-term outcomes of TV repair and replacement in a large surgical series of TVIE cases among PWID.…”

Section: Invited Commentarymentioning

confidence: 99%

“…In Egypt, it seems the philosophy is similar, although medication assistedtherapy is not used. 6 Operative technique offers further risk mitigation strategies; specifically the avoidance of prosthetic material. Prosthetic valve replacement in the tricuspid and mitral positions carries a greater risk of reinfection than valve repairs.…”

Section: Invited Commentarymentioning

confidence: 99%

Invited Commentary

Witten

Gordon

Shrestha

et al. 2020

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis

Xie¹,

Chen²,

He³

et al. 2023

BMC Cardiovasc Disord

View full text Add to dashboard Cite

Background Owing to the increase in both intravenous drug injections and intracardiac and vascular interventional treatments among drug users, the incidence of infective endocarditis (IE) involving the tricuspid valve, which sits between the two right heart chambers, has gradually increased. This study aimed to compare the clinical outcomes of different surgical procedures for tricuspid infective endocarditis (TIE). Methods We retrospectively analyzed fifty-six patients who underwent tricuspid valve surgery at our hospital from January 2006 to August 2019. All patients were diagnosed with TIE and indicated a need for surgery. Perioperative and follow-up data were collected to summarize and analyze the clinical outcomes of different surgical approaches, including tricuspid valvuloplasty (TVP) and tricuspid valve replacement (TVR) for TIE. Results Cardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, postoperative mechanical ventilation time, and intensive care unit (ICU) stay time were shorter in the TVP group than in the TVR group. Additionally, the incidence of red blood cell transfusion and postoperative complications was lower in the TVP group than in the TVR group. The postoperative 30-day mortality rates were similar between both the groups. Fifty-two patients were followed up for an average of 5.50 ± 3.79 years. The postoperative 3-, 5-, and 7-year survival rates were 100%, 100%, and 95.5% in the TVP group and 96.7%, 96.7%, and 96.7% in the TVR group, respectively. The 5-year and 10-year reoperation rates were 0% and 0% in the TVP group and 6.7% and 20% in the TVR group, respectively. Conclusion Both TVR and TVP for TIE significantly improved the functional status of the heart with satisfactory efficacy. TVP was found to be superior to TVR in reducing the need for postoperative blood transfusions, reducing the risk of postoperative complications, and reducing the need for long-term reoperations.

show abstract

Evaluation of Tricuspid Valve Repair Without Annuloplasty Ring in Intravenous Drug Abusers

Abstract: Patients and MethodsThis retrospective, observational, nonrandomized study included all patients presenting with isolated tricuspid valve endocarditis due to IV drug abuse and who had undergone tricuspid valve repair or replacement between

Cited by 3 publications

References 11 publications

Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis

Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis

Invited Commentary

Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis

Contact Info

Product

Resources

About